Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.
Heartflow has raised $98.0M in total funding. The most recent round was Convertible Note. The last funding was announced in March 2025.
Heartflow's investors include Wellington Management, Janus Henderson Investors, U.S. Venture Partners, Bain Capital Life Sciences, Fidelity.
Heartflow is headquartered in Mountain View, United States.
Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.
Heartflow is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Heartflow — Funding & Investors." VCBacked, March 26, 2025, https://www.vcbacked.co/company/heartflow. Accessed August 14, 2026.
VCBacked. (2025). Heartflow — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/heartflow
{{cite web |title=Heartflow — Funding & Investors |url=https://www.vcbacked.co/company/heartflow |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated